Literature DB >> 22982945

The impact of inflammation to the antioxidant defense parameters in AMD patients.

Emina Čolak1, Nada Majkić-Singh, Lepša Žoric, Aleksandra Radosavljević, Natalija Kosanović-Jaković.   

Abstract

BACKGROUND AND AIMS: Oxidative stress and inflammation are postulated to be involved in the pathogenesis of the age-related macular degeneration (AMD) although the mechanism linking the oxidation and inflammation is still unknown. The aim of this study was the analysis of the antioxidant capacity measured by levels of the antioxidant enzymes: superoxide dismutase (SOD), glutathione peroxidase (GPx), glutathione reductase (GR) and total antioxidant status (TAS) along with the inflammatory markers such as Creactive protein (CRP), interleukin-6 (IL-6) and fibrinogen in AMD patients in order to analyze the relationship of the inflammatory markers with the antioxidant parameters and their association with AMD.
METHODS: The cross-sectional study, carried out in the University clinical setting, included 84 patients with the age-related macular degeneration, aged 71.25±7.14 years and 84 aged-matched control subjects (CG).
RESULTS: Statistical analysis revealed significantly lower GR (p=0.007) and TAS (p<0.000) values in the group of AMD patients compared to the controls. Logistic regression analysis showed that higher values of inflammatory markers (CRP>3 mg/L, IL>4.9 pg/mL, fibrinogen>3.8 g/L) and lower values of antioxidative parameters (SOD<900 U/gHb, GR<55 U/L and TAS<1.15 mmol/L) were significantly associated with AMD (ORCRP: 1.29, 95% CI 0.54-3.12, p<0.05; ORIL-6: 3.53, 95% CI 1.16-10.75, p=0.024; ORFIB: 3.06, 95% CI 1.78-7.92, p=0.019; ORSOD: 2.39, 95% CI 0.78-7.35, p<0.05; ORGR: 4.04, 95% CI 1.28-12.73, p=0.013; ORTAS: 2.9, 95% CI 1.4- 6.3, p=0.032).
CONCLUSIONS: Based on the results obtained, it may be concluded that the antioxidant defense system was significantly reduced in patients with AMD and the probability to develop AMD was higher in older individuals with lower values of antioxidant parameters and higher values of inflammatory markers.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22982945     DOI: 10.3275/8593

Source DB:  PubMed          Journal:  Aging Clin Exp Res        ISSN: 1594-0667            Impact factor:   3.636


  6 in total

Review 1.  Hydrogen Sulfide: Novel Endogenous and Exogenous Modulator of Oxidative Stress in Retinal Degeneration Diseases.

Authors:  Panpan Li; Hanhan Liu; Xin Shi; Verena Prokosch
Journal:  Molecules       Date:  2021-04-21       Impact factor: 4.411

2.  NLRP3 Upregulation in Retinal Pigment Epithelium in Age-Related Macular Degeneration.

Authors:  Yujuan Wang; Jakub W Hanus; Mones S Abu-Asab; Defen Shen; Alexander Ogilvy; Jingxing Ou; Xi K Chu; Guangpu Shi; Wei Li; Shusheng Wang; Chi-Chao Chan
Journal:  Int J Mol Sci       Date:  2016-01-08       Impact factor: 5.923

3.  The association of enzymatic and non-enzymatic antioxidant defense parameters with inflammatory markers in patients with exudative form of age-related macular degeneration.

Authors:  Emina Čolak; Svetlana Ignjatović; Aleksandra Radosavljević; Lepša Žorić
Journal:  J Clin Biochem Nutr       Date:  2017-02-08       Impact factor: 3.114

4.  L-2-oxothiazolidine-4-carboxylic acid attenuates oxidative stress and inflammation in retinal pigment epithelium.

Authors:  Wanwisa Promsote; Rajalakshmi Veeranan-Karmegam; Sudha Ananth; Defen Shen; Chi-Chao Chan; Nevin A Lambert; Vadivel Ganapathy; Pamela M Martin
Journal:  Mol Vis       Date:  2014-01-07       Impact factor: 2.367

5.  Pigment epithelium-derived factor reduces apoptosis and pro-inflammatory cytokine gene expression in a murine model of focal retinal degeneration.

Authors:  Yujuan Wang; Preeti Subramanian; Defen Shen; Jingsheng Tuo; S Patricia Becerra; Chi-Chao Chan
Journal:  ASN Neuro       Date:  2013-11-26       Impact factor: 4.146

6.  Platelet-derived growth factor (PDGF)-C inhibits neuroretinal apoptosis in a murine model of focal retinal degeneration.

Authors:  Yujuan Wang; Mones S Abu-Asab; Cheng-Rong Yu; Zhongshu Tang; Defen Shen; Jingsheng Tuo; Xuri Li; Chi-Chao Chan
Journal:  Lab Invest       Date:  2014-04-07       Impact factor: 5.662

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.